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Interleukin Iac and interleukin 6 promote the in vitro
growth of both normal and neoplastic human cervical
epithelial cells
G Castrilli, D Tatone, MG Diodoro, S Rosini, M Piantelli and P Musiani
Department of Human Pathology, 'G D'Annunzio' University c/o SEBI., via dei Vestini, 1-66100 Chieti, Italy
Summary Interleukin 1a (IL-ia), Interleukin 6 (IL-6) and epidermal growth factor (EGF) were tested for their ability to regulate epithelial
cervical cell cytokine production and secretion and to induce proliferation of human normal and neoplastic epithelial cervical cells. IL-1a, and
IL-6 enhanced tumour and normal cell growth by 20-120%. The interleukins efficacy was similar to that of EGF for some cell lines but not for
normal esocervical cells. The stimulatory effects of the interleukins were observed in both human papilloma virus (HPV)-infected and HPV-
non-infected cervical cells. Normal cells constitutively expressed IL-i a, IL-6 and EGF mRNA. All cell lines except C33A expressed IL-i a
mRNA. CaSki, C-411 and HT-3 expressed mRNA for IL-6. IL-1 a induced or increased IL-6 mRNA levels in the Me-180 and HT-3 lines and in
normal cervical cells. IL-6 induced: (1) the expression of its own mRNA only in Me-180 cells that constitutively lacked IL-6 mRNA; (2) the
expression of IL-1 a mRNA in C-33A and increased IL-1 a mRNA level in the case of Mei 80 cells. Increased amounts of IL-6 mRNA were found
in normal cells when treated with IL-1a. In spite of the pattern of mRNA expression, only HT-3 and normal cervical cells constitutively secreted
IL-6, and only normal cells were able to produce IL-1a protein. A significant IL-1a-dependent increase of IL-6 secretion was found in Me-180,
HT-3 and normal cells. IL-ia- and IL-6-driven cell proliferations were almost completely inhibited by the addition of neutralizing anti-IL-6
antibodies. Taken together, these data suggest that interleukins play a role in cervical carcinogenesis as autocrine and/or paracrine stimuli.
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A number ofstudies have drawn attention to factors released from
a tumour itself, or by accompanying non-neoplastic stromal cells,
that may facilitate their growth in the host. These include the
proinflammatory lymphokines IL-la and IL-6, which exert a
pleiotropic effect on cell growth and differentiation because of
their ability to modulate expression ofgenes for cell receptors and
growth factors (Dinarello and Wolff, 1993; Tracey and Cerami,
1993). IL-6, in particular, can act as a growth factor in a number of
human tumour cells, including acute myeloid leukaemia, multiple
myeloma, ovarian and renal carcinoma and melanoma (Miki et al,
1989; Reibnegger et al, 1991; Wu et al, 1992; Tartour et al, 1994).
Chronic inflammation contributes to the pathogenesis of different
cancer types (Correa, 1992; Kawai et al, 1993). In the uterine
cervix, inflammation produced by the coexistence ofseveral sexu-
ally transmitted diseases usually precedes and then accompanies
cervical cancer (Schmauz et al, 1989; Koutsky et al, 1992).
Proinflammatory cytokines, such as IL-la and IL-6, produced in
this context constitute a paracrine stimulus for tumourgrowth. The
possible coexistence of an autocrine loop is supported by studies
indicating the production of IL-la and IL-6 by squamous
epithelia, including the ectocervix (Eustace et al, 1993;
Woodworth and Simpson, 1993). IL-la and IL-6 also stimulate
the growth of human papilloma virus-immortalized and carci-
noma-derived cervical epithelial cells (Iglesias et al, 1995;
Woodworth et al, 1995). In this work, we corroborate these data
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and extend them to normal cervical cells, and we also compare the
extent ofthe IL- la and IL-6 stimulatory effect with that produced
by epidermal growth factor (EGF). Our findings suggest that IL-
1a and IL-6 can play a role in cervical tumour progression.
MATERIALS AND METHODS
Cervical cell cultures
Normal epithelial cervical cells were isolated using a two-step
enzymatic digestion with dispase and trypsin, as described by
Pirisi et al (1988). Briefly, tissues from hysterectomies for
endometriosis or fibroids were incubated overnight at4°C in phos-
phate-buffered saline (PBS) containing 25 U ml-l of dispase
(Gibco-Life Technologies, Grand Island, NY, USA). On the
following day, the ectocervical epithelium was lifted from the
submucosa, recovered as an intact sheet, and further incubated at
37°C for 30 min in the presence of 0.13% trypsin (Gibco Life
Technologies) with frequent agitation. Single-cell preparations
were seeded and cultured in collagen IV-coated plates (Becton
Dickinson, Bedford, MA, USA) in complete MCDB153 medium,
i.e. in MCDB153 base medium (Sigma, Milan, Italy) supple-
mented with 25 gg ml- of bovine pituitary extract (BPE, Becton
Dickinson), 0.2 ng ml-1 human recombinant EGF (Becton
Dickinson), 5 ,ug ml insulin, 5 ,ug ml' transferrin, 2 mm gluta-
mine, 0.1 mm phosphoethanolamine and 0.1 mm ethanolamine
(Sigma). The purity of these preparations was checked by
immunostaining with anti-cytokeratin 14 and anti-cytokeratin 18
antibodies (Woodworth et al, 1993). Cervical carcinoma cell lines
(ME-180, C-411, CaSki, HT-3 and C-33A) were obtained from
ATCC (Rockville, MD, USA) and maintained in culture as
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Table 1 Sequences of primers used for PCR analysis
Primer Primer sequence Length of PCR product (bp)
IL-la 5'-CAAGGAGAGCATGGTGGTAGTAGCMCCAACG 491
3'-TAGTGCCGTGAGTTTCCCAGAAGAAGAGGAGG
IL-6 5'-ATGAACTCCTTCTCCACAAGCGC 628
3'-GAAGAGCCCTCAGGCTGGACTG
EGF 5'-TCTCAACACATGCTAGTGGCTGAAATCATGG 527
3'-TCAATATACATGCACACACCATCATGGAGGC
IL-10 5'-GCCTAACATGCTTCGAGATC 204
3'-TGATGTCTGGGTCTTGGTTC
G3PDH 5'-ACCACAGTCCATGCCATCAC 452
3'-TCCACCACCCTGTTGCTGTA
' 300
0 200-
a)
0.
ME-180 C-411 CaSki HT-3 C-33A Normal 1 Normal 2
Cells
Figure 1 Effect of CL-1 a, I -6 and EGHF on neoplastic and normal esocervical
cell growth. Increase of cell growth (%) = (cell number in the presence of
each cytokine/cell number in the absence of cytokine -1) x 100. Values
represent the mean of three independent experiments ± s.d. The number of
cells (mean ± s.d.) in cytokine-treated samples were compared with the
number of cells (mean ± s.d.) in the corresponding (control) value using
Student's t-test.* P<0.005;**P<0.05
directed by ATCC in media supplemented with 10% heat-inacti-
vated fetal calf serum (FCS).
Cell growth assay
Normal and neoplastic cells (1-3x 104 cells ml-') in complete
MCDB153 medium were plated into 24-well plates. Collagen IV-
coated plates were used for normal cell cultures. After 18 h, the
cells were rinsed once with PBS and then maintained in complete
MCDB153 medium without EGF and BPE in the presence or
absence ofcytokines. Optimal cytokine concentrations, as assessed
by preliminary experiments, were 100 U ml, 50 U ml-' and 2.5 U
ml- for ILl-a, IL-6 and EGF (PeproTech, London, UK) respec-
tively. Specific activities were 10000 U ig-' forIL-la, 5000 U ig-'
for IL-6 and 500 U jg-' for EGF. Quadruplicate haemocytometer
counts oftriplicate cultures were performed after 7-11 days.
Neutralization
To test the ability of specific monoclonal anti-IL-6 neutralizing
antibodies (anti-IL-6, Genzyme, Cambridge, MA, USA) to block
the growth-enhancing effect displayed by exogenous IL-la, IL-6
and EGF on cervical cells, cells were plated as above and then
incubated in the presence or in the absence ofthese cytokines with
(10 jg ml-') or without anti-IL-6 antibodies.
Elisa
The amounts of IL-la, IL-6, and EGF in cervical cell cultures
were quantified by specific ELISA kits (Amersham International,
Little Chalfont, UK; Oncogene Science, Cambridge, MA, USA).
Normal and neoplastic cells (0.5 x 106 cells ml-) in complete
MCDB153 medium were plated into 24-well plates. Collagen IV-
coated plates were used for normal cell cultures. After 18 h the
cells were rinsed twice with PBS, maintained in complete
MCDB153 medium without EGF and BPE for 24 h, rinsed again
twice with PBS and then cultured for an additional 24 h in the
same medium (without EGF and BPE) in the presence or absence
of cytokines. At the end of the incubation period, cell-free super-
natants were collected and supplemented with protease inhibitors
including phenylmethylsulphonyl fluoride and leupeptin (Sigma)
at 2 jg mll each. ELISA tests were performed as indicated by the
manufacturer.
Message amplification by reverse transcription-PCR
Normal and neoplastic cells were seeded in 60-mm Petri dishes,
cultured and treated with cytokines (for 24 h), as reported for
ELISA assay. Total RNA was isolated from cells grown in culture
by a guanidinium thiocyanate- phenol-chloroform extraction and
alcohol precipitation procedure using the Ultraspec RNA isolation
system (Biotecx, Houston, TX, USA). Extracted RNA was
analysed for integrity using electrophoresis through a 2%
formaldehyde-agarose gel. The amount of total RNA was quanti-
fied by reading its absorption at 260 nm.
Total RNA (1 jg) was reverse transcribed in a final volume ofa
20 gl reaction mixture containing: 10 mM Tris-HCl (pH 8.3), 50
mm potassium chloride, 5 mm magnesium chloride, 400 jM of
dATP, dCTP, dGTP and dTTP (Pharmacia, Piscataway, NJ, USA),
2.5 jiM oligo dT primers, 20 units RNAase inhibitor, and 50 units
murine leukaemia virus reverse transcriptase (Perkin-Elmer Cetus,
Norwalk, CT, USA). The mixture was incubated at room tempera-
ture for 30 min, at 42°C for 30 min, heated to 95°C for 5 min and
stored at -20°C. cDNA was denatured by heating to 95°C for
5 min; then lji was added to a 50-jil reaction mixture containing
5 gl of 10 x polymerase chain reaction (PCR) reaction buffer [0.5
M potassium chloride, 0.1M Tris-HCl (pH 8.3), 15 mm, magnesium
chloride 0.1% gelatin], 100 gM deoxynucleotide (Pharmacia),
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Figure 2 Constitutive expression of mRNA specific for human IL-1a, IL-6,
EGF and IL-10 in normal cervical cells, as determined by RT-PCR. Lane M
contains the size marker (p Xi 74 DNA/HaeIII. The size of the corresponding
PCR products is indicated at the left
Table 2 Constitutive and cytokine-induced expression of IL-1 a mRNA, IL-6
mRNA and EGF mRNA in neoplastic and non-neoplastic cervical cells
Treatment
None IL-1a IL-6 EGF
IL-1 a mRNA
Me-180 + + ++ +
HT-3 ++ ++ ++ ++
C-33A _ + + _
CaSki ++ ND ND ND
C-411 + ND ND ND
Normal 1 ++ ++ ++ ++
Normal 2 ++ ND ND ND
IL-6 mRNA
Me-180 - + +
HT-3 + ++ + +
C-33A _ _ _ _
CaSki + ND ND ND
C-411 + ND ND ND
Normal 1 + ++ + +
Normal 2 + ++ + +
EGF mRNA
Me-180 + + + ++
HT-3 + + + +
C-33A _ _ _ _
CaSki + ND ND ND
C-411 - ND ND ND
Normal 1 + + + +
Normal 2 + + + +
-, Not detected; +, weak expression; ++, moderate expression; ND, not
done.
400 nM ofeach ofthe two primers (Clontech, Palo Alto, CA, USA)
and 2.0 units ofTaq polymerase (Perkin ElmerCetus) and water. A
negative control consisting of an aliquot without the addition of
cDNA was included in each amplification. Amplification was
performed with a thermocycler (Hybaid, Teddington, UK) for 30
cycles of45 s at 940C for denaturation, 45 s at 600 C for annealing
and 2 min at 720 C for primer extension. After amplification, PCR
products were electrophoresed in 1.5% agarose (Gibco BRL,
Gaithersburg, MD, USA) and stained with ethidium bromide; size
markers from (p X174 DNA digested with HaeIII endonuclease
(Gibco BRL) were included. Amplified cDNA fragments were
visualized with a UV transilluminator. Specific bands were identi-
fied by their anticipated molecular weight and by comparison with
amplified cDNA from control templates. Oligonucleotide primers
for G3PDH, IL-la, IL-6, IL-10 and EGF (Table 1) and their
control template cDNAs were purchased from Clontech.
Normal c-rvix ME--180
A B 1 2 3 4 M 1 2 3 4
G3DPH
(452 bp
IL-1
(491 bp)
EGF
(527 bp)
IL-6
(628 bp;
Figure 3 Constitutive (lane 1), IL-1a-(lane 2), IL-6-(lane 3) and EGF-induced
(lane 4) production of mRNA specific for human IL-1a, EGF and IL-6 in
normal cervical cells and in the ME-180 cancer cell line, as determined by
RT-PCR. Lane M contains the size marker (p X174 DNA/HaelIl. A positive
control; B, negative control. The size of the corresponding PCR products is
indicated at the right
PCR analysis performed as reported above is not really quantita-
tive. However, a strong increase in the intensity of a band after a
given treatment strongly suggests a parallel increase in the corre-
sponding mRNA level.
RESULTS
Two proinflammatory cytokines, IL-I a and IL-6, were tested for
their ability to regulate epithelial cervical cell cytokine production
and secretion and to induce proliferation of human normal and
neoplastic epithelial cervical cells. In addition, their activities were
compared with those of EGF. Experiments were carried out in
defined serum-free medium, as FCS is complex and contains
factors capable ofinfluencing cell growth and cytokine production.
Optimal concentrations of IL-1a and IL-6 significantly
enhanced tumour and normal cell growth from 20-120% (Figure
1). As expected, all neoplastic and normal cervical cells were
sensitive to the stimulatory effect of EGF. The magnitude of this
effect was similar to that of IL-la and IL-6 in the case of ME-180
and CaSki cell lines, whereas it was significantly higher in the
remaining lines and in normal cervical cells (Student's t-test; P <
0.05 for C-33A and P < 0.005 for the other cells). The effects of
IL-la, IL-6 and EGF were dose dependent (data not shown), and
their stimulatory effects were observed in both HPV-infected (ME-
180, C4-II and CaSki) and HPV- non-infected (HT-3, C-33A and
normal) cervical cells.
To validate a possible autocrine role for IL-la, IL-6 and EGF,
we analysed their secretion and expression of the corresponding
mRNA by ELISA and reverse transcription-polymerase chain
reaction (RT-PCR) respectively. Normal cells constitutively
expressed IL-1a, IL-6 and EGF mRNA, though at different levels
(Figure 2), the band of IL-la mRNA being more prominent than
those of IL-6 and EGF.
All cell lines except C33A expressed IL-la mRNA (Table 2). In
addition, unlike ME-l80 and C-33A, CaSki, C-411 and HT-3
expressed mRNA for IL-6. As reported in the same table, Me-180,
HT3 and CaSki cells were also able to produce mRNA for EGF.
Exogenously added IL-la induced (Table 2 and Figure 3): (1)
the expression of its own mRNA only in C33A cells that constitu-
tively lacked IL- la mRNA; (2) the expression of IL-6 mRNA in
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Table 3 Constitutive and cytokine-induced expression of IL-1a and IL-6 in
neoplastic and non-neoplastic cervical cells
Treatment
None IL-la IL-6 EGF
IL-1 a
Me-180 <3a ND <3 <3
HT-3 <3 ND' <3 <3
C-33A <3 ND <3 <3
Normal 1 <3 ND <3 <3
Normal 2 7 ND 5 9
IL-6
Me-180 < 3 13 ND 12
HT-3 127 926 ND 161
C-33A <3 <3 ND <3
Normal 1 11 39 ND 14
Normal 2 16 44 ND 3
aResults are expressed as pg ml-' per 106 cells per 24 h. ND, not done.
EGF Lr r
EGF + anti-IL-6
IL-1
IL-1 + anti-IL-6
IL-6
IL-6 + anti-IL-6
Anti-IL-6
Anti-OKT3 1EJ o Normal
* HT-3
* ME-108
-30 70 170 270
Percentage of control
Figure 4 Effects of neutralizing anti-IL-6 antibodies on the growth enhancing
effect of IL-1a, IL-6 and EGF in normal esocervical cells and in HT-3 and ME-
180 cell lines. Results are expressed as percentage of control, (cell number
in treated samples/cell number in untreated samples -1) x 100, and
represents the mean of two different experiments, the maximal difference
observed between the two being less than 20%
Me-180, and strengthened the bands relative to IL-6 mRNA in the
HT-3 cell line and in normal cervical cells.
Exogenously added IL-6 induced: (1) the expression of its own
mRNA only in Me-180 cells that constitutively lacked IL-6
mRNA; (2) the expression of IL-la mRNA in C-33A, and
strengthened the band relative to IL-la mRNA in the case of Me
180 cells. The constitutive levels of IL-la and EGF mRNAs in
normal cervical cells were not modified by exogenous IL- la, IL-6
or EGF, whereas stronger bands corresponding to IL-6 mRNA
were observed when these cells were treated with IL-ia.
In spite of the pattern of mRNA expression, only HT-3 and
normal cervical cells constitutively secreted IL-6, and only normal
cells were able to produce IL-la protein (Table 3). A significant
increase ofIL-6 secretion was found in Me-180, HT-3 and normal
cervical cells cultured in the presence ofIL-la. The levels ofEGF
protein in supernatants from both stimulated and unstimulated
normal and neoplastic cells were in all cases less than 10 pg ml-'.
Exogenous IL-Ia and IL-6-driven cell proliferations were
almost completely inhibited by the addition of neutralizing anti-
IL-6 antibodies (Figure 4). This antibody treatment was ineffective
against EGF-stimulated cell growth.
DISCUSSION
Normal epithelial cervical cells were, as expected, highly sensitive
to the stimulatory effect of EGF while neoplastic cells, though
always stimulated, varied in their sensitivity to this cytokine. Both
proinflammatory cytokines IL-I and IL-6 increased the growth not
only of cells from neoplastic cervix, as reported (Iglesias et al,
1995; Woodworth et al, 1995), but also of normal, non HPV-
immortalized cells. Our observations on normal cervical cells
slightly differ from those data showing that IL-la (Woodworth et
al, 1995) and IL-6 (Iglesias et al, 1995) do not affect, oronly mini-
mally increase, the growth of normal non-HPV-infected ectocer-
vical cells. This lack ofeffect may be due to the absence ofinsulin
and transferrin in the culture medium as we have found that the
stimulatory effect ofboth these interleukins and EGFis insulin and
transferrin dependent (unpublished observations). In addition, the
presence of insulin and transferrin is an absolute requirement for
the IL-6- and EGF-dependent proliferation of normal human
epidermal keratinocytes (Elder et al, 1992).
It is also to be noted that the modulatory effect of IL-la, IL-6
and EGF does notdepend on the presence ofHPV, as it is observed
in HPV+ and HPV- tumour cells and in the HPV- normal counter-
part. In vitro data on the effects of proinflammatory cytokines
on normal and neoplastic cells suggest that they may promote
growth in vivo when produced in response to inflammation or
tissue damage. In this way, infection with several sexually trans-
mitted agents becomes a risk factor for cervical neoplasia.
Chronic inflammation, too, contributes to the pathogenesis of
several types of cancer other than cervical forms (Correa, 1992;
Kawai et al, 1993). Many cell types contribute to cytokine
production within the cervix; reactive cells, in particular macro-
phages, produce not only IL-lac and IL-6 but also EGF
(O'Sullivan et al, 1993). An additional local source of IL-6 are
human cervical fibroblasts, which constitutively secrete this
cytokine (Iglesias et al, 1995).
An autocrine stimulatory role of IL- la, IL-6 and EGF is
suggested by the presence of mRNA for these cytokines in both
neoplastic and normal cervical cells. In spite ofmRNAexpression,
significant protein production, by normal cells and some cancer
cell lines, was only observed in the case of IL-6. Autocrine IL-6
could thus play a role in cervical cell growth, at least in some
cases. IL-i a increases IL-6 mRNA expression and IL-6 secretion
but does not modify these parameters for EGF. However, IL-6
plays a pivotal role in IL-la-stimulated cell growth, as anti-IL-6
antibodies abrogate the effect ofIL-la.
The study of IL-6 regulatory function on growth of epithelial
cervical cells is ofparticularinterest, because increased IL-6 levels
have been reported in both the serum (Breen et al, 1990) and cere-
brospinal fluid (Gallo et al, 1989) of HIV-infected patients. In
addition, in vitro infection of normal monocytes/macrophages
with HIV induces gene expression and secretion of IL-6
(Nakajima et al, 1988).
HIV-infected women form a unique subset of cervical carci-
noma patients with more aggressive disease and a poorer prog-
nosis (Maiman et al, 1990, 1993). This aggressiveness could be, at
least, partly dependent on abnormal IL-6 production.
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